Akynzeo launch = dog

Really sad to hear Eisai oncology is still so screwed up that they can't even get reimbursement in order before a launch.

I'm not sure which is worse, that they couldn't get contracts and reimbursement support together in the first place or that they decided to launch.

Either way it sure sucks for the reps. Helsinn must be pulling their hair out.

 

FC already pulled all his out.

 

And KAMs & DMs pressuring Sales to somehow "communicate" to accounts the Nov 21 Initial buy date deadline and Buyback info

How about Eisai Brand team gets its act together first

Ok, probably won't happen

 

Former Eisai here. Don't know the details, but it appears (as usual for Eisai) way over-complicating contracting.

 

Greedy Helsinn is behind this. An oral with no reimbursement support is a joke. They know the IV should have come out and they screwed that up. This is a dog.

 

RDs pressuring dms to hound the sales force to document activities?

 

Eisai best practices at work!

 

Former MGI then Eisai (against my will)

Helsinn treated the sales force with respect and appreciation, amazing European awards trips.
Eisai should thank their lucky stars that company has not already bailed on this chicken-shit outfit. Failed product launches and failed clinical trials are par for the course at Eisai.

No reimbursement in place at launch? What a surprise. NOT

 

So how's the dog doing? Wcl? Anyone?

 

Colazal will save the day!

 

Webex =fail

 

What the heck is Colazal? Regardless, Belviq was supposed to save the day too.
Whatever it is Eisai can be counted to either screw up the approval or screw up the launch.

Laughing stock of the community of oncology reps. Sad for the few good oncology reps who continue to hang in there with this basket case of a leadership team.

 

Lenvatinib is a home run.

 

No sales for akhnzeo again. Ugh

 

Eisai is in oncology?

 

Lenvima coming strong

 

And so is stink in a turd!

 

Has anyone sold any akynzeo yet?

 

$5 worth. Cash money!

 

Sweet